HIGHLIGHTS
- who: January and colleagues from the Renmin Hospital, Wuhan University, China have published the research work: Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune in fi ltration in pancreatic cancer, in the Journal: (JOURNAL)
- what: In this study, the high expression of signature lncRNAs in PC cell lines was investigated by PCR experiment. According to this model, the risk score was calculated for individual patients in the training cohort, the validation cohort, and the entire TCGA cohort. Naturally, this study assessed whether the risk score was associated with PC gene mutation. In the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.